This year's AHA Scientific Sessions is nearly here, and as Chair of the program committee for this annual event, I can genuinely attest that the content this year is among the most compelling we've ever seen. The depth and diversity, ranging from cross-disciplinary science, late breakers, and clinical case sessions, promises to satisfy all interests and specialties.
AHA has assembled an exceptional suite of tools to enhance your Sessions experience. I encourage you to access the meeting planner and app via the following links:
- Meeting planner: https://ahasessions2023.mapyourshow.com/8_0/sessions/#/%20meeting%20planner
- Download the app: https://professional.heart.org/en/meetings/scientific-sessions/programming/mobile-app-guide-scientific-sessions
I’d love to connect with you in person or via X (formerly Twitter), @dramitkhera, where I will be posting highlights throughout the conference and sharing news about all the exciting developments at UT Southwestern.
I look forward to hearing from you, and hope you have a productive and rewarding conference!
Amit Khera, M.D., M.Sc., FACC, FAHA, FASPC
Professor of Internal Medicine | Division of Cardiology
Director, Preventive Cardiology
UT Southwestern Medical Center
Dallas, TX
SESSIONS:
Opening Session
Amit Khera
Chair Opening Remarks
8:02 - 8:12a
Main Event I
Obesity - Novel Therapeutics and Implications for Population Health
Amit Khera
Moderator
8:30 - 9:15a
Main Event I
Obesity - Novel Therapeutics and Implications for Population Health
Abraham Lincoff
Semaglutide and Cardiovascular Outcomes in Patients with Overweight or Obesity Who Do Not Have Diabetes
8:30 - 8:42a
Main Event 1
Traditional and Non-Traditional Risk Factors for CVD: Women and Sex Differences
Haekyung Jeon-Slaughter
Ten-Year Atherosclerotic Cardiovascular Risk Trajectory Among Women Veterans Diagnosed with Breast, Colorectal, Lung, and Thyroid Cancer
9:30 - 9:35a
MDP148
Novel Biomarkers for Cardiovascular Health and Disease
Lena Mathews
Matrilysin (MMP7) as a Robust Predictor of Hypertension Incidence and Complications: Findings From a Proteomic Analysis in the Atherosclerosis Risk in Communities (ARIC) Study
9:40 - 9:45a
Zone 3, ST Hall, Lvl 2: 473
I Dream of Genes: Genetics, Genomics, and Gene Regulation
Hesham Sadek
A Novel Screening Approach Ideentifies New Drug for Genetic Based Cardiomyopathy
9:45 - 9:57a
119AB
Hot Topics in Management of Coromary Artery Disease/Acute Coronary Syndrome
Stefan James
DAPA-MI - A Registry-Based Randomized Trial of Dapagliflozin in Patients With Acute Myocardial Infarction Without Diabetes
9:45 - 9:57a
Main Event I
Looking Into Vascular and Cardiac Dysfunction Through Molecular Mechanisms and Imaging
Matthew Gold
Racial Differences in Peripheral Microvasculature's Association With Mild Cognitive Impairment
9:45 - 9:55a
126A
Traditional and Non-Traditional Risk Factors for CVD: Women and Sex Differences
Tiffany Brazile
Sex Differences in Cardiac and Vascular Function With Healthy Aging: Implications for Greater Risk of HFpEF in Women
10:00 - 10:05a
MDP151
Exploring the Relationship between Cardiomyopathy with Mind, Body, Wellness, and Environment
Noelle Pavlovic
Association of Fatigue Subtype With Echocardiographic Measurees of Cardiac Structure and Function in Prevalent HF in the Atherosclerosis Risk in Communities Study
10:00 - 10:05a
MDP165
Updates from the Health Tech Advisory Group
Mujeeb Basit
Health Tech Track
10:00 - 10:05a
Health Innovation Pavillion
Updates from the Health Tech Advisory Group
Eric Peterson
Novel Lifestyle and Medical Therapies for Improving Cardiovascular Prevention
10:05 - 10:15a
Health Innovation Pavillion
Novel Biomarkers for Cardiovascular Health and Disease
Diego Ramonfaur
Proteomic Measures Linking Social Determinants of Health to Heart Failure Risk: The Atherosclerosis Risk in Communities Study
10:30 - 10:35a
Zone 3, ST Hall, Lvl 2: 478
Obesity, Adiposity, and CVD: New Insights Regarding a Growing Challenge
Sandeep Das
Poster Professor
11:30 - 12:45p
Zone 3, ST Hall, Lvl 2
Beyond Traditional Models: Innovations in Cardiovascular Risk Prediction and Precision Medicine
Parag Joshi
Poster Professor
11:30 - 12:45p
Zone 3, ST Hall, Lvl 2
Emerging Genomic Mechanisms of Cardiovascular Disease
Seyedmohammad Saadatagah
Clonal Hematopoiesis Driven by TET2 and ASXL1 but Not DNMT3A is Associated With Interleukin 6 Levels, Cardiac Biomarkers, Cardiac Remodeling, and Risk of Atrial Fibrillation
11:30 - 12:45p
Board #1101
SGLT2s in Heart Failure: Above and Beyond GDMT
Andrew Ambrosy
Baseline Kidney Function and the Effects of Dapagliflozin on Health Status in Heart Failure: A Pooled Patient-Level Analysis from DFEINE-HF and PRESERVED-HF
11:30 - 12:45p
Board #2153
Novel Strategies and Approaches to Care in Heart Failure
May Xac
Outpatient Effort to Improve Medication Uptitration and Maintenance (OPTIMUM)
11:30 - 12:45p
Board #2191
Enter the Matrix: Stimulations, AI, Telemedicine, and Cardiomyopathy
Julia Foote
Development and External Validation of De Novo Simulation Model to Inform Implementation Strategies for Guideline-Directed Medical Therapy of Heart Failure With Reduced Ejection Fraction
11:30 - 12:45p
Board #200
Amyloid and Sarcoid: Disparities, Mortality, Risk Factors, and Outcomes
Ravi Thakker
Poster: Outcomes With Pulmonary Artery Catheter Use in Cardiogenic Shock Patients
11:30 - 12:45p
Board #2228
iRobot: Revolutionizing Cardiac CT with AI-Powered Innovations for Precision Diagnosis and Unleashing New Frontiers in Cardiovascular CT!
Fernando Kay
Deep-Learning-Based Assessment of Left Atrial Volume in Coronary Calcium CT: Association With NT-proBNP and Clinical Outcomes
11:30 - 12:45p
Board #2335
Drugs, Drugs, and More Drugs: New Pharmacologic Insights in Heart Failure Management
Yuekai Ji
Association of Coagulation Factor XI Levels with Cardiac Function and Cardiovascular Events: The Atherosclerosis Risk in Communities (ARIC) Study
11:30 - 12:45p
Board #3005
Obesity, Adiposity, and CVD: New Insights Regarding a Growing Challenge
Arsalan Hamid
The Independent and Joint Associations of Obesity and Hypertension on Incident Heart Failure: A Pooled Cohort Analysis
11:30 - 12:45p
Board #3011
Ischemic Heart Disease in Women, with or without CAD
Van-Khue Ton
Impact of Female Sex on Cardiogenic Shock Outcomes - A Cardiogenic Shock Working Group Report
11:30 - 12:45p
Board #3138
The Glass Ceiling hasn't been Shattered Yet: Inequities in Authorship and Clinical Inclusion
Alfonso Martinez de Majo
Trends in Representation of Authorship From Low and Low-Middle-Income Countries in Cardiology Journals Over the Last Two Decades: We Need More Representation
11:30 - 12:45p
Board #3144
Running Towards Improved Cardiovascular Health: Physical Activity, Exercise Capacity and CVD Risk
Ali Noorbaksh
Effects of Yearlong High Intensity Aerobic Exercise on Reducing Left Atrial Epicardial Adipose Tissue
11:30 - 12:45p
Board #3198
Running Towards Improved Cardiovascular Health: Physical Activity, Exercise Capacity and CVD Risk
Ali Noorbaksh
Characterizing Regional and Global Effects of Epicardial Adipose Tissue on Left Atrial Function
11:30 - 12:45
Board #3199
Running Towards Improved Cardiovascular Health: Physical Activity, Exercise Capacity and CVD Risk
Julianna West
Association Between Moderate and Vigorous Physical Activity on Long-Term Heart Failure Risk: The Cooper Center Longitudinal Study
11:30 - 12:45p
Board #3203
How Essential are Life's Essential 8? The Influence of Exercise, Nutrition and Sleep on Cardiovascular Health
Foster Osei Baah
Physical Activity and Nutrition Self-Efficacy Associates With Perceived Everyday Discrimination in African American Women: The Step It Up Physical Activity Intervention
11:30 - 12:45p
Board #4185
Building the Translational Toolkit: Novel Biomarkers, Clinical Predictors, and Epidemiologic Models of PAH
Megan Griffiths
An Artifical Intelligence-Derived Pediatric Pulmonary Hypertension Risk Prediction Model From the Pediatric Pulmonary Hypertension Network (PPHNet) Registry
11:30 - 12:45p
Board #4233
Renewing Heartbeats with Advanced Heart Failure and Transplantation Therapies
Jameson Wilbur
Clinical Outcomes and Predictors of Vasoplegia in Patients Undergoing Orthotopic Cardiac Transplantation at a High-Volume Single-Center
11:30 - 12:45p
Board #4298
Therapeutic Interventions for Improving Life and Limb Outcomes in PAD Patients
Angela Wang
Chronic Kidney Disease in an Important Predictor of 2-Year Mortality After Chronic Limb Ischemia Repair Using Either Endovascular or Bypass Graft Intervention
11:30 - 12:45p
Board #4324
Therapeutic Interventions for Improving Life and Limb Outcomes in PAD Patients
David Fernandez Vazquez
Comparative Outcomes of Femoropopliteal Intravascular Ultrasound Interventions: A Report From the XLPAD Registry
11:30 - 12:45p
Board #4325
Best of AHA Specialty Conferences: BCVS 2023
Yena Oh
Transcriptional Heterogeneity Of The Postnatal Cardiac Conduction System
11:30 - 12:45p
BCVS15
Best of AHA Specialty Conferences: BCVS 2023
Vivek Jani
Cardiomyocyte Mechanics In Animal Models Of Heart Failure With Preserved Ejection Fraction
11:30 - 12:45p
BCVS16
Can't Weight to Discuss Obesity Measures and Weight Loss Strategies!
Naveed Sattar
Does Weight Reduction Drive the Reduction in Blood Pressure in People Living With Obesity Treated Tirzepatide?: Insights From SURMOUNT-1 Study
12:20 - 12:25p
MDP52
The Road Less Traveled: Diverse Career Options in Cardiology
Amit Khera
Panel Participant
1:30 - 1:35p
Lounge, ST Hall, Lvl 2
Ready for Liftoff: Recent Advances in PAH Pathobiology for Translation
Carly Blatt
IGFBP8 as a Novel Biomarker for Hemodynamics and Functional Status in Pulmonary Arterial Hypertension
1:45 - 1:55p
102AB- 294
Louis N. and Arnold M. Katz Basic Science Research Prize for Early Career Investigatos Competition
Peiheng Gan
Myocardin Condensation Drives Cell Lineage Specification During Cardiogenesis
1:45 - 1:55p
119AB- 71
Uncovering the Mysteries of Heart Failure Diagnosis and Evaluation
Henri Lu
Determinants of Right Ventricular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial Experience
2:00 - 2:05p
Zone 2, ST Hall, Lvl 2: 521
Uncovering the Mysteries of Heart Failure Diagnosis and Evaluation
Xiaowen Wang
Age-Related Echocardiographic Characteristics in Patients With Heart Failure With Preserved Ejection Fraction in PARAGON-HF
2:10 - 2:15p
Zone 2, ST Hall, Lvl 2: 522
Quest Diagnostics and Steve Rusckowski Early Career Investigator Award for Preventive Cardiovascular Medicine Research Competition
Kershaw Patel
Modeling the Optimal Strategy of Natriuretic Peptide Testing for Heart Failure Prevention in Diabetes: A Pooled Cohort Analysis
2:15 - 2:25p
103B- 362
Coronary Imaging in Prevention Trials: Past, Present, and Future
Rina Mauricio
Casse 3
2:20 - 2:23p
204C
Robert Levy Memorial Lecture and Lifestyle and Cardiometabolic Health Early Career Investigator Award Competition
Emily Decicco
Lipid-Lowering Therapy and LDL-C Control for Primary Prevention in Persons With Diabtes Across 90 Health Systems in the United States
2:30 - 2:40p
201AB- 234
Targeting Vascular Cells and New Treatment in Atherosclerosis
Lorraine Mascarenhas
Association of Central Arterial Stiffness With Atrial Myopathy: The Atherosclerosis Risk In Communities (ARIC) Study
3:00 - 4:15p
Board #1031
Metabolomics and Proteomics of Cardiovascular Disease
Victoria Lamberson
Network Analysis Identifies Partially Distinct Plasma Protein Associations Underlying HFpEF and HFrEF
3:00 - 4:15p
Board #1104
Metabolomics and Proteomics of Cardiovascular Disease
Yimin Yang
Proteomic Associations with Late-Life Cardiac Structure and Function: The Atherosclerosis Risk in Communities Study
3:00 - 4:15p
Board #1107
Metabolomics and Proteomics of Cardiovascular Disease
Anne Marie Reimer Jensen
Proteomic Associations of Cardiac Function Trajectories Through Mid- to Late Life
3:00 - 4:15p
Board #1109
Congenital and Acquired Pediatric Heart Disease Potpourri I
Dustin Nash
Arrhythmias in Acute Care Cardiology: Prevalence, Therapies, and Outcomes- An Analysis of the Pediatric Acute Care Cardiology collaborative (PAC3) Database
3:00 - 4:15p
Board #2034
Clinical EP Diagnosis: Epidemiology and Landscapes
Anna Rosenblatt
Temporal Trends and Race Differences in Catheter Ablation for Atrial Fibrillation Among Patients with Heart Failure With Reduced Ejection Fraction Before and After CASTLE-AF
3:00 - 4:15p
Board #2139
The Brightest and the Best of Heart Failure Research
Carlos Tovar
O2 Pulse is Not Stroke Volume: Changes in Oxygen Pulse Do Not Reliably Track Changes in Stroke Volume During Exercise in Health or Heart Failure
3:00 - 4:15p
Board #2239
The Latest and Greatest in Heart Failure Research
Daisuke Kamimura
Electrocardiographic T Wave Inversion and Cardiac Structure and Function
3:00 - 4:15p
Board #2270
Hot Topics in Heart Failure Research
Victoria Lamberson
Plasma Proteomics and Risk of Incident HFpEF and HFrEF: The Atherosclerosis Risk in Communities Study
3:00 - 4:15p
Board #2306
Hot Topics in Heart Failure Research
Henri Lu
Cardiac Structure and Function and Renal Outcomes in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the PARAGON-HF Trial
3:00 - 4:15p
Board #2307
Echo and Cardiac Symphony: Unveiling Rhythms, Unlocking Function, Defeating the Heart's Limitations!
Sheng Nan Chang
Cardiac Structure and Function Predict Incident Atrial Fibrillation and Flutter in Patients With HFpEF - Lessons From PARAGON-HF
3:00 - 4:15p
Board #2370
Patiently Weighting for Therapies: Obesity Management Strategies
Nishant Shah
Aspirin Dosing by Body Mass Index: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness
3:00 - 4:15p
Board #3023
Racial and Ethnic Disparities in Cardiovascular Health and Mortality
Spencer V. Carter
Racial and Ethnic Differences in the Diagnostic Yield of Cardiomyopathy, Aortopathy, and Arrythmia Genetic Testing and Frequency of Family Variant Screening
3:00 - 4:15p
Board #3102
Socioeconomic Disparities and Cardiovascular Health
Diana de Oliveira Gomes
Cardiometabolic Risk Increased in All Socioeconomic Status During the Venezuelan Humanitarian Crisis: The EVESCAM Cohort Study
3:00 - 4:15p
Board #3120
Cutting Edge Approaches to Cardiovascular Prediction and Prevention
Thomas Nguyen
Factors Associated with Changes in High Sensitivity Troponin and NT-proBNP in Response to Intensive Blood Pressure Lowering in SPRINT
3:00 - 4:15p
Board #3216
From Risk Enhancer to Risk Assessment: Expanding Utilization of CAC Scoring
Alexander Razavi
Coronary Artery Calcium for Risk Stratification Among Persons With Very-High High-Density Lipoprotein Cholesterol
3:00 - 4:15p
Board #3218
From Risk Enhancer to Risk Assessment: Expanding Utilization of CAC Scoring
Shyon Parsa
Coronary Artery Calcium Distribution Patterns Are Independently Predictive of Adverse Cardovascular Events: Observations From the Dallas Heart Study
3:00 - 4:15p
Board #3223
Mitochondrial and Metabolic Mechanisms of Pulmonary Vascular Diseases and RV Failure
Carly Blatt
Slit2/ROBO4 Ligand-Receptor Pair as Novel Biomarkers for Survival in Pulmonary Arterial Hypertension
3:00 - 4:15p
Board #4245
Careers in Health Tech - What is Possible and How to Find It
Duwayne Willett
Becoming and Leading as an Effective CMIO
3:15 - 3:23p
201AB
Cardiovascular Risk Factos and Stroke Prediction
Wendy Wang
Association of Left Atrial Function With Vascular Brain Injury: The Atherosclerosis Risk in Communities Neurocognitive Studdy (ARIC-NCS)
3:15 - 3:25p
112AB- 345
Melvin L. Marcus Early Career Investigator Award in Cardiovascular Sciences Competition
Glynnis Garry
Induction of Cardiac Reprogramming Following Injury Through Delivery of a Single Factor, PHF7
3:15 - 3:25p
119AB- 74
Cardiac Arrest on the Athletic Field: A Team Approach
Benjamin Levine
Full-Court Press: Emergency Preparedness
3:25 - 3:35p
Main Event II
Using Drugs, Diet and Delivery to Optimize Hypertension Outcomes
Deepak Gupta
Effects of Dietary Sodium on Systolic Blood Pressure in Middle-Aged Individuals: A Randomized Order Cross-Over Trial
3:45 - 3:55p
Main Event I
Laennec Fellow in Training (FIT) Clinician Award Competition
Reynaldo Sanchez
A Tale of Two Maladies: An Interplay of Mendelian Priciples
4:00 - 4:10p
105AB- 185
Jay D. Coffman Early Career Investigator Award Competition
Victoria Thomas
PAD Raising Awareness in Sacred Environments ""Praise""
4:00 - 4:10p
103B- 358
Cardiac Rehab - Why Do We Keep Failing?
Ambarish Pandey
Moderator
8:00 - 9:15a
104AB
Late-Breaking Basic Science Oral Abstracts II
Neelima Thottappillil
Transcriptomic Mapping of Human Blood Vessels Defines Spatially Restricted Adventitial Progenitor Niche
8:00 - 8:10a
126A- LBBS06
Rapid Fire: More Sessions on Atrial Fibrillation Ablation… Get Ready!!
Christopher Joseph
Quantification of Recent Reporting Rates of Atrioesophageal Fistula After Left Atrial Ablation for the Treatment of Atrial Fibrillation
9:30 - 9:35a
Zone 4, ST Hall, Lvl 2- 437
European Heart Journal Session
Joseph Hill
Moderator
9:45 - 11:00a
201AB
ChatGPT, Ambient AI, Emotional AI, and other Novel Tech Solutions Demystified for the Clinician
Eric Peterson
Moderator
9:45 - 11:00a
205C
Pro-Con Debates on the Pathogenesis and Management of Pulmonary Hypertension
Megan Griffiths
Social Media Moderator
9:45 - 11:00a
102AB
The Great Debate: Controversial Topics in Cardio-Oncology
Nathanya Baez Hernandez
Social Media Moderator
9:45 - 11:00a
204B
European Heart Journal Session
Amit Khera
The Year in Cardiovascular Medicine: Dyslipidemias
9:45 - 9:57a
201AB
Research and Clinical Transformation through Platform Technology (AI, CRM, and Application Engagement)
Janeta Nikolovski
The Heartline Experience: Can Digital Health Technology Trials Achieve Long-Term Participant Engagement?
9:50 - 9:55a
Zone 3, ST Hall, Lvl 2- 467
AI and Scientific Publications- Perspective of Journal Editors: Joint Session of JAMA and Circulation Journals
Joseph Hill
Panel Participant
10:05 - 10:15a
Health Innovation Pavillion
Implementation and Intervention Strategies to Improve Blood Pressure Control and Reduce Cardiovascular Disease
Spencer Shastid
Association of Intensive vs Standard Blood Pressure Lowering With 1-year and 2-year Changes in Cardiac Biomarker Levels: Findings from SPRINT
10:10 - 10:15a
MDP201
Cardiovascular Disease in Chronic Kidney Disease: New Horizons from the Bench to Bedside
Arsalan Hamid
Inflammatory Chronic Kidney Disease is Associated With Incident Heart Failure: A Pooled Cohort Analysis
10:15 - 10:25a
116
Implementation and Intervention Strategies to Improve Blood Pressure Control and Reduce Cardiovascular Disease
Wanpen Vongpatanasin
Potassium Magnesium Citrate is Superior to Potassium Chloride in Reversing Metabolic Side Effects of Chlorthalidone
10:30 - 10:35a
MDP203
Atrial Fibrillation: Early Intervention, More Power, More Closure
Jose Joglar
Panel Participant
10:33 - 11:00a
113BC
Cardiovascular Disease in Chronic Kidney Disease: New Horizons from the Bench to Bedside
Bethany Roehm
Prognostic Value of Creatinine vs Cystatin C-Based Estimation of Glomerular Filtration Rate for Mortality in Heart Failure
10:45 - 10:55a
116- 253
Health Technology Competition - Part II
Eric Peterson
Lead Judge
11:15 - 1:15p
Health Innovation Pavillion
The Triangulation of Comorbidities, Cardiomyopathy, and Outcomes
Mark Drazner
Poster Professor
11:30 - 12:45p
Zone 2, ST Hall, Lvl 2
Endothelial Function in Health and Diseases
Alexander Sullivan
Acipimox Does Not Improve Endothelial Function and Insulin-Stimulated Vasodilation in Patients With Metabolic Syndrome
11:30 - 12:45p
Board #1004
Endothelial Function in Health and Diseases
Alexander Sullivan
Salsalate Does Not Improve Endothelial Function and Insulin-Stimulated Vasodilation in Patients with Metabolic Syndrome
11:30 - 12:45p
Board #1005
Gender Considerations and Outcomes in Cardiomyopathy
Niharika Neela
Prescription of Teratogenic Medications for Reproductive-Age Women With Heart Failure With Reduced Ejection Fraction in a Safety-Net Health System
11:30 - 12:45p
Board #2174
More Than Just LVEF: Considering Other Risk and Prognostic Indicators of Outcomes in Cardiomyopathy
Adedoyin Johnson
Relationship Between Hospital Care Team Segregation Index and Cardiovascular Care for Black and White Patients
11:30 - 12:45p
Board #2208
The Role of Age in Cardiovascular Health: Focus on Aging and Older Adults
Daokun Sun
Association Between Left Atrial Function and Frailty: The Atherosclerosis Risk in Communities (ARIC) Study
10:00 - 12:45p
Board #3054
Neighborhood and Multilevel Social Determinants of Health in Association with Cardiovascular Health
Rani Zierath
Precision of Phenotyping of Social Determinants of Health and Risk of Coronary Disease, Heart Failure, and Stroke: The Jackson Heart Study
11:30 - 12:45p
Board #3080
Exercise testing for screening, diagnostic, and physiologic applications
Merje Chukumerije
Outcomes of Sports Participation for Black Athletes With Implantable Cardioverter-Defibrillators: Data From the ICD Sports Registry
11:30 - 12:45p
Board #3208
Lipids and Cardiovascular Disease: Mechanisms of Risk
Sandy Reynolds
The Associations Between Loneliness and Circulating Lipoproteins as Well as Diabetes Risk in African-American Women Residing in Resource-Limited Neighborhoods: Data From the Step It Up Physical Activity Intervention
11:30 - 12:45p
Board #3219
The Quality Quest: Understanding Variation in Cardiovascular Care Patterns
Elliott Miller
Mechanical Circulatory Support in Patients Without Cardiogenic Shock Undergoing Percutaneous Coronary Intervention
11:30 - 12:45p
Board #3239
Targeted Therapies and Vascular Complications in Cardio-Oncology
Michael Poliner
Real World Cardiovascular Events With Next Generation Bruton's Tyrosine Kinase Inhibitors - An Updated Analysis
11:30 - 12:45p
Board #4060
Patient Related, Patient Reported, Patient Centric Data and Discovery for Better Health Care Delivery in Peripheral Vascular Disease
Blake Bruneman
Comparative Outcomes of Below-the-Knee Stent Deployment Interventions: A Report From the XLPAD Registry
11:30 - 12:45p
Board #4294
Best of AHA Specialty Conferences: ISC 2023
Kent Simmonds
Racial Disparities In The Treatment Of Post-Stroke Complications Among Acute Stroke Patients
11:30 - 12:45p
Board # 199- ISC33
Multi-Omic Mechanisms Underlying Diseases of Cardiovascular Aging
Khaled Shelbaya
Large-Scale Plasma Proteomics Identifies C1QTNF1 as a Potential Casual Risk Factor for Aortic Stenosis
12:00 - 12:05p
MDP134
Novel Modeling and AI-Informed Approaches to Cardiovascular Data
Ankit Maheshwari
Prediction of Embolic Stroke in People Without Atrial Fibrillation and Prior Stroke Using Measures of Atrial Myopathy: The Atherosclerosis Risk in Communities (ARIC) Study
12:40 - 12:45p
MDP96
Multi-Omic Mechanisms Underlying Diseases of Cardiovascular Aging
Andrew Perry
Proteomic Architecture of Faility Across the Spectrum of Cardiovascular Disease
12:50 - 12:55p
MDP139
Look into the Crystall Ball: Predictors, Prediction Models, and Cardiomyopathy
Sahmin Lee
Cardiac Structure and Function in Relation to Health-Related Quality of Life in Heart Failure Patients With Preserved Ejection Fraction: Results From the PARAGON-HF Study
1:00 - 1:05p
Zone 2, ST Hall, Lvl 2- 534
Disrupting the Status Quo to Improve Cardiovascular Care Delivery
Jaskeerat Gulati
Implementation of a Resident-Led cardiac Point-of-Care Ultrasound Curriculum for the Internal Medicine Residency Program at UT Southwestern
2:00 - 2:05p
Zone 4, ST Hall, Lvl 2- 591
Rapid Fire: Clinical Trials in Cardiac Rehabilitation and Prevention
Douglas Kyrouac
Effects of Year Long Aerobic Exercise on Left Atrial Size In Patients With Left Ventricular Hypertrophy
2:50 - 2:55p
Zone 3, ST Hall, Lvl 2- 582
Disrupting the Status Quo to Improve Cardiovascular Care Delivery
Anita Osabutey
Facilitated Peer Mentoring: A Novel for Promoting Equitable and Inclusive Mentoring for Underrepresented Trainees in Academic Medicine
2:50 - 2:55p
Zone 4, ST Hall, Lvl 2- 596
Circulation: Innovation in Cardiovascular Scieence and Medicine: An AHA Journal Session
James de Lemos
Moderator
3:30 - 4:45p
121B
Artificial Intelligence's Impact on Quality of Care: Debates on Opportunities and Risks
Mujeeb Basit
Moderator
3:30 - 4:45p
202AB
Novel Implantable Device Therapies for Arrhythmia and Heart Failure Management
Jose Joglar
Resynchronization Therapy: CRT, LBBBAP, or Both?
3:30 - 3:38p
113A
Late-Breaking Science: Future of Lipid Lowering Therapy - Noveel Mechanisms and Approaches
Parag Joshi
Social Media Moderator
3:30 - 4:45p
Main Event I
Breaking Barriers: Understanding and Improving Access to Cardiovascular Care for All
Neil Keshvani
Poster Professor
3:30 - 4:45p
Zone 3, ST Hall, Lvl 2
Ventricular Remodeling I
Peder Myhre
Concentrations of Troponin I but Not Cardiac Troponin T Are Associated With 7-year Changes in Left Ventricular Structure and Function in Older Adults: ARIC
3:30 - 4:45
Board #1041
Unraveling the Genetic Tapestry of Cardiovascular Disease
Leo Buckley
Associations of SGLT2 Inhibitor-Related Plasma Proteins With Incident Heart Failure: ARIC
3:30 - 4:45p
Board #1070
All You Wanted to Ask About Heart Failure and Did Not Know Where to Find Out - From Iron Deficiency to Devices and More
Kayvon Ghoreshi
Immune Function Assay by Race/Ethnicity Within the First Yeart After Heart Transplantation
3:30 - 4:45p
Board #2247
Hemodynamics and Functional Research
Diana de Oliveira Gomes
Blood Pressure Responses to Exercise in Patients With Heart Failure With Preserved Ejection Fraction: The Importance of Normalizing Blood Pressuer to Workload
3:30 - 4:45p
Board #2261
Hemodynamics and Functional Research
William Turlington
Systolic-Diastolic Coupling and Cardiac Limitations to Exercise in Patients with Hypertrophic Cardiomyopathy
3:30 - 4:45p
Board #2262
Hemodynamics and Functional Research
Jan Hoenemann
14 Days of Sever, Sustained Normobaric Hypoxic Enhances Left Venticular Contractility in Patients After Myocardial Infarction
3:30 - 4:45p
Board #2263
Hemodynamics and Functional Research
Joetsaroop Bagga
Right and Left Ventricular Starling Function in Heart Failure With Preserved Ejection Fraction
3:30 - 4:45p
Board #2266
Hemodynamics and Functional Research
Denis Wakeham
Pulse Pressure Amplification Contributes to the Exaggerated Peripheral Blood Pressure Response to Exercise in Patients Witth HFpEF
3:30 - 4:45p
Board #2269
Emerging Biomarkers and Other Predictors of Risk I
Matthew Segar
Biomarker-Based Phenomapping in Chronic Stable HFpEF and Exercise Capacity: An Analysis of the RELAX Trial
3:30 - 4:45p
Board #2276
Too Sweet! Blood Pressure, Retinopathy, and other Risk Factors in Diabetes
Justin Echouffo
Diabetic Retinopathy and Risk of Heart Failure Subtypes: ARIC
3:30 - 4:45p
Board #3023
Connecting Cardiovascular Risk with Chronic Kidney Disease
Zainali Chunawala
Recurrent Admission of Acute Decompensated Heart Failure Among Patients With and Without PAD and Its Significance in the CKD Population: ARIC Cohort Study
3:30 - 4:45p
Board #3034
Biomarkers, Metabolomics, and Genomics in Cardiovascular Disease
Kausik Ray
Predictors of Elevated High-Sensitivity C-Reactive Protein in a US Population With Atherosclerotic Cardiovascular Disease: Results fom the National Health and Nutrition Examination Survey
3:30 - 4:45p
Board #3107
Novel Markers of Cardiovascular Function, Health, and Disease in Cohort Studies
Chunxiao Zhang
Association of Left Atrial Function with Mitral Regurgitation Progression: ARIC
3:30 - 4:45p
Board #3110
Breaking Barriers: Understanding and Improving Access to Cardiovascular Care for All
Hunter Mwansa
Provider Care Team Segregation and Ischemic Heart Disease Outcomes by Race
3:30 - 4:45p
Board #3262
Breaking Barriers: Understanding and Improving Access to Cardiovascular Care for All
Sarah Godfrey
Reducing Health care Disparities by Improving ICD Knowledge in a Diverse Population, a Quality Improvement Initiative to Align ICD Settings With Goals of Care
3:30 - 4:5p
Board #3265
Targeting Cardiovascular Risk: Novel Insights from the World of Prevention
Ann Marie Navar
Low Rates of Achievement of Low-Density Lipoprotein Cholesterol Levels
3:30 - 4:45p
Board #3278
Updates in Endovascular Therapies and Treatment for Peripheral Vascular Disease
Zainali Chunawala
Comparison of Drug-Eluting Stent With Bare-Metal Stent Implantation in Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis
3:30 - 4:45p
Board #4171
Prospective Associations of Lifestyle, Social, and Genetic Factors with Cardiovascular Risk and Mortality
Ijeoma Eleazu
Associations of Cumulative Perceived Stress With Cardiovascular Risk Factors and Outcomes: Findings From the Dallas Heart Study
3:30 - 4:45p
MDP100
Innovative Care Pathways and Patient-Centered Outcomes: Paving the Way Optimal Management
Nicholas Hendren
A Self-Administered Home Inotrope Program for Unfunded Patients With End-Stage Heart Failure
8:00 - 8:10a
202AB- 311
AI in the Clinic and Lab: Promise, Pitfalls, and the Data Police
James de Lemos
Do We Need to Call the Data Police?
8:36 - 8:48a
Main Event II
Featured Science: Exercise is Life (and Death) - Approaches in Athletes, Arrhythmias, and Heart Failure
Rachel Lampert
Vigorous Exercise in Individuals With Long QT Syndrome (LQTS): Primary Results of the Prospective, Multinational Lifestyle and Exercise in LQTS (LIVE-LQTS) Study
10:00 - 10:10a
203AB
Put to the Test: Blood ad Urine-based Biomarkers for Cardiovascular Disease
James de Lemos
Poster Professor
10:30 - 11:45a
Zone 3, ST Hall, Lvl 2
Proteomics and Biomarkers
Lajjaben Patel
The Association of Soluble Fms-Like Tyrosine Kinase-1 (sflt-1) With Risk of Heart Failure and Atial Fibrillation: Insights From the Dallas Heart Study
10:30 - 11:45a
Board #1045
Pediatric Heart Failure and Transplantation
Ian Ergui
In-Hospital Outcomes After Cardiac Transplantation in Patients With Autism Spectrum Disorders: Insights From the National Inpatient Sample 2011-2019
10:30 - 11:45a
Board #2001
Exercise testing for screening, diagnostic, and physiologic applications
Arpanjeet Kaur
Meta-Analysis of Randomized Controlled Trials Comparing Ablation Targets Beyond Pulmonary Vein Isolation vs Pulmonary Vein Isolation With Persistent Atrial Fibrillation
10:30 - 11:45a
Board #2065
Environmental Factors Associated with Cardiovascular Risk and Mortality
Robert Meade
Quantifying the Cardiovascular Burden of Extreme Heat: A Meta-Analysis of Over 400 Laboratory-Based Heat Exposure Studies
10:30 - 11:45a
Board #3002
Drug Treatments and Supplements in Epidemiological Studies of CVD
Samuel Slavin
Statin Twitter: Human and 'Bot' Contributions 2010 - 2022
10:30 - 11:45a
Board #3061
Drug Treatments and Supplements in Epidemiological Studies of CVD
Kayvon Ghoreshi
Affordability of Insulin for Non-Elderly Adults in the US Following $35 Monthly Out-of-Pocket Cap
10:30 - 11:45a
Board #3069
Physical Activity for Cardiometabolic Disease Prevention and Management II
Sheila Hegde
Proteomic Measures Associated With Leisure-Time Physical Activity and Heart Risk in Late-Life - ARIC
10:30 - 11:45a
Board #3166
Physical Activity for Cardiometabolic Disease Prevention and Management II
Rachel Skow
Whole Body vs Small Muscle Mass Exercise Training in Patients with Heart Failure with Preserved Ejection Fraction: Impact on Peripheral Responses to Exercise
10:30 - 11:45a
Board #3169
Physical Activity for Cardiometabolic Disease Prevention and Management II
Abhinav Saurabh
Physical Activity is Associated with Monocytes and Monocyte Subsets in Low-Resourced Neighborhoods: Data From the Step It Up Physical Activity Intervention
10:30 - 11:45a
Board #3175
Put to the Test: Blood ad Urine-based Biomarkers for Cardiovascular Disease
Zainali Chunawala
Biomarker Enhanced Risk Prediction of Incident Heart Failure in Low-Risk Patients: ARIC Study
10:30 - 11:45a
Board #3195
From Artificial Intelligence to Biomarker-based Approaches: Novel Strategies for CVD Risk Prognostication and Prevention
Shawn Simek
A Deep Learning Algorithm to Estimate Left Ventricular Mass from Coronary Calcium CT Scans: Association with Incident Failure Events from DHS
10:30 - 11:45a
Board #3197
From the Heart to the Brain: Updates in Hypertension Epidemiology
Devin Haney
Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels with Cognitive Outcomes in SPRINT
10:30 - 11:45a
Board #4122
Shock Talk: Critical Discussions About Cardiogenic Shock Care
Amit Saha
Characterization of Patient-Specific Care Pathways in Cardiogenic Shock
10:30 - 11:45a
Board #4192
Vascular Zebras and Big Data- What to Know and Where to Go
Sarah Weideman
Comparative Outcomes of Below-the-Knee Atherectomy Interventions: A Report from the XLPAD Registry
10:30 - 11:45a
Board #4297
Frontiers of Innovation in CV Risk Assessment
Bige Ozkan
NT-proBNP Trajectories and HF Risk Associations in Middle to Older Ages in Adulthood: ARIC Study
12:20 - 12:25p
MDP279
Thomas Smith Memorial Lecture
Joseph Hill
HFpEF
1:30 - 1:50p
119AB
Navigating the Data Maze: Epidemiological Insights into CV Outcomes
Jennifer Thibodeau
Poster Professor
1:30 - 2:45p
Zone 3, ST Hall, Lvl 2
Hyping Up Heart Failure Research
Henri Lu
Multiparameter Right Ventricular Dysfunction Predicts Worse Prognosis in HF with Preserved Ejection Fraction - Lessons from the PARAGON-HF Trial
1:30 - 2:45p
Board #2248
Multi-Omics Approaches for CVD Risk Prediction
Khaled Shelbaya
Large Scale Plasma Proteomics Identifies MMP-12 as a Novel Biomarker of Aortic Stenosis Progression
1:30 - 2:45p
Board #3220
To Inhibit of Not to Inhibit SGLT2? Preclinical and Clinical Insights into HFrEF and HFpEF
Joseph Hill
SGLT2 Inhibitors: Clinical Questions for HFpEF That Are Yet to Be Answered Back to the Lab
3:30 - 3:45p
119AB
Spotlight on Cardiac Regeneration
Olaf Bergmann
Unloading Reveals a Latent Cardiomyocyte Regeneration Potential in the Human Heart
3:45 - 3:55p
120A- 102